Health X Platform (BOM:533259) Beta: 0.7914 (As of Jun. 30, 2026)


BOM:533259 Health X Platform Ltd BOM:533259
69 GF Score
Price ₹319.45
GF Value ₹380.60
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Health X Platform Beta?

Health X Platform BOM:533259 -2.20% 69 Beta is 0.7914 as of Jun. 30, 2026. GuruFocus rates BOM:533259 with a GF Score™ of 69/100 and a GF Value™ of ₹380.60 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Health X Platform's Beta is 0.7914.


Health X Platform  (BOM:533259) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Health X Platform Beta Related Terms


Health X Platform Beta Historical Data

* Premium members only.

The historical data trend for Health X Platform's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health X Platform Beta Chart

Health X Platform Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.76 0.21 0.96 0.94

Health X Platform Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.96 1.03 1.04 1.18 0.94

Health X Platform Beta Competitor Comparison

For the Pharmaceutical Retailers subindustry, Health X Platform's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health X Platform Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health X Platform's Beta distribution charts can be found below:

* The bar in red indicates where Health X Platform's Beta falls into.


BOM:533259
69GF Score
Health X Platform Ltd BOM:533259
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health X Platform Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7914 mean?
Health X Platform (BOM:533259) has a Beta of 0.7914 as of Jun. 30, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Health X Platform and its competitors.
Is Health X Platform's Beta too high?
Health X Platform's current Beta is 0.7914. Overall, Health X Platform has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Health X Platform's Beta compare to competitors?
Health X Platform's Beta of 0.7914 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Health X Platform and its competitors. Health X Platform's current Beta is 0.7914. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health X Platform stock overvalued right now?
Based on GuruFocus' analysis, Health X Platform (BOM:533259) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹380.60, compared to a current price of ₹319.45 — trading 16.1% below its estimated fair value. The current Beta is 0.7914. Health X Platform's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Health X Platform (BOM:533259), the current Beta is 0.7914 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health X Platform (BOM:533259) Overvalued in 2026?

Based on GuruFocus' analysis, Health X Platform stock appears to be undervalued. The current stock price of ₹319.45 is trading 16.1% below its estimated GF Value™ of ₹380.60. GuruFocus considers Health X Platform to be Modestly Undervalued.

Key valuation signals for BOM:533259:

  • Beta: 0.7914
  • GF Value™: ₹380.60 vs. price of ₹319.45 (16.1% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the BOM:533259 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Health X Platform Business Description

Other Exchanges HEALTHX:India
Address 7 Abanindra Nath Thakur Sarani, Azimganj House, 2nd Floor, Kolkata, WB, IND, 700017
Health X Platform Ltd, formerly Sastasundar Ventures Ltd is a Core Investment Company. Through its subsidiaries, the company is focused on the business of digital network of healthcare and portfolio management services. Its business segments are; Financial Services, and Healthcare Network. The majority of its revenue is generated from the Healthcare Network segment which includes activities for pathology and marketing of healthcare and OTC products through e-commerce portal and diagnostic services which consist of pathological/radiological investigations. Geographically, the company operates only in India.
69GF Score

Get the complete analysis for BOM:533259

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹319.45
Price
₹380.60
GF Value